Tafinlar
(dabrafenib)dabrafenib 50 MG Oral Capsule [Tafinlar]dabrafenib 75 MG Oral Capsule [Tafinlar]
NO BLACK BOX WARNING
Dosage & administration
eficacy, safety & testing
Tafinlar clinical details
Mechanism of Action (MOA): BRAF+ Advanced Melanoma or BRAF+ Melanoma Involving Lymph Nodes After Surgery
Efficacy [Adjuvant]: BRAF+ Advanced Melanoma or BRAF+ Melanoma Involving Lymph Nodes After Surgery
Efficacy [Metastatic]: BRAF+ Advanced Melanoma or BRAF+ Melanoma Involving Lymph Nodes After Surgery
Safety Profile: BRAF+ Advanced Melanoma or BRAF+ Melanoma Involving Lymph Nodes After Surgery
Dosing & Administration: BRAF+ Advanced Melanoma or BRAF+ Melanoma Involving Lymph Nodes After Surgery
Mechanism of Action (MOA): Unresectable or Metastatic BRAF V600E+ Solid Tumors
BRAF Testing: Unresectable or Metastatic BRAF V600E+ Solid Tumors
Efficacy: Unresectable or Metastatic BRAF V600E+ Solid Tumors
Safety Profile: Unresectable or Metastatic BRAF V600E+ Solid Tumors
Dosing & Administration: Unresectable or Metastatic BRAF V600E+ Solid Tumors
BRAF600E Testing: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
Mechanism of Action (MOA): Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
Efficacy: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
Safety Profile: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
Dosing & Administration: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
drug label
Tafinlar prescribing information
Have more Tafinlar questions?
Submit MSL Request
Learn More
Your request will be referred to the appropriate Novartis Pharmaceuticals Corporation medical professional, such as a Tafinlar pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Tafinlar issue?
ONLINE FORMReport adverse event
Learn More
You can report a Tafinlar adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Tafinlar Prior authorization resources
NOT PROVIDED BY BRANDComplete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
NOT PROVIDED BY BRANDCoverage Authorization Appeals
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
PANO Service Request Form - Patient
PANO Service Request Form - HCP
PANO Service Request Form - Tafinlar + Mekinist (PDF): HCP
PANO Service Request Form - Tafinlar (PDF): HCP
PANO Service Request Form - Mekinist (PDF): HCP
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
NOT PROVIDED BY BRANDReimbursement help (FRM) resources
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Tafinlar Financial assistance options
Co-pay savings program
commercial only
Enroll in Patient Savings Program - Mekinist
Enroll in Patient Savings Program - Tafinlar
Enroll in Patient Savings Program - Tafinlar + Mekinist
Learn More
Overview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Learn More
Overview
- Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
- Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
- 100% free (outside of insurance)
Patient eligibility
- HCP must enroll patient
- May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
- Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
PANO Service Request Form - Patient
PANO Service Request Form - HCP
PANO Service Request Form - Tafinlar + Mekinist (PDF): HCP
PANO Service Request Form - Tafinlar (PDF): HCP
PANO Service Request Form - Mekinist (PDF): HCP
Learn More
Overview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Tafinlar Patient education
Getting started on Tafinlar
NOT PROVIDED BY BRANDInstructions For Use: Unresectable or Metastatic BRAF V600E+ Solid Tumors
NOT PROVIDED BY BRANDInstructions For Use: BRAF+ Melanoma
NOT PROVIDED BY BRANDInstructions For Use: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
Patient toolkit
About Taflinlar + Mekinist: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tafinlar + Mekinist: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Caregiver Resources: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: BRAF+ Melanoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
About Tafinlar + Mekinist: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tafinlar + Mekinist: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Managing Side Effects: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Metastatic Non-Small Cell Lung Cancer (NSCLC) With BRAF V600E Mutation
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Fever Management Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
people also ask
Tafinlar FAQs
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
Can't find what you're looking for?
Our trained staff can help you:Please note:
- Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
- Samples are provided at the discretion of the brand.
- We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.